GlobalWafers Co Ltd (6488)
Taiwan OTC Exchange · Taiwan · prices in TWD · close of 22 Oct 2026
Key indicators
| Last close | TWD 826.00 |
|---|---|
| 52-week range | 333.00 – 1,600.00 |
| Return, 1 month / 3 months | −14.9% / −33.4% |
| Return, 1 year / 3 years | +57.2% / +85.5% |
| Trend | Above 200-day, below 50-day |
| RSI (14) | 35 |
| Volatility (1 year) | 81.4% |
| Worst drawdown (1 year) | -48.4% |
| Average daily value traded | 11,049.84M TWD |
| Dividend yield | 0.9% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
GlobalWafers is a Taiwanese maker of silicon wafers that serve as the starting material for semiconductor chips. The company produces polished and epitaxial wafers in various sizes and supplies them to chip manufacturers and foundries that serve electronics, communications and industrial markets. It also offers related wafer services and has grown its production footprint through acquisitions of other wafer producers. GlobalWafers is based in Hsinchu, Taiwan, and sells to customers across Asia, Europe and North America.
GlobalWafers Co Ltd trades under the code 6488 on the Taiwan OTC Exchange in Taiwan, with its price quoted in New Taiwan dollars (TWD). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
GlobalWafers Co Ltd (6488) trades on the Taiwan OTC Exchange in Taiwan. It last closed at TWD 826.00 on 22 October 2026.
Its price-based Market X-Ray is 54 out of 100 (a fair price profile), ranking 478 of 1,093 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 57.2% and over the last three months it fell 33.4%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Taiwan OTC Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 63 · Fair | Mixed trend against its averages. | |
| Above 200-day average | 7.0% | ||
| From 52-week high | -45.5% | ||
| Momentum | 61 · Fair | Typical recent returns for this exchange. | |
| 3-month return | -33.4% | ||
| 6-month return | 38.2% | ||
| 12-month return, skipping the last month | 84.8% | ||
| Stability (higher is calmer) | 17 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 81.4% | ||
| Worst drawdown, 1 year (smaller is calmer) | -48.4% | ||
| Liquidity | 100 · Strong | Trades actively. | |
| Average daily value traded | 11,049.84M TWD | ||
| Zero-volume days | 0.0% | ||
| Income | 39 · Weak | Dividend is small or irregular. | |
| Dividend yield | 0.9% | ||
| Years with dividends | 5 |
Strengths
- Liquidity: Trades actively.
Weak spots
- Stability (higher is calmer): Volatile, with deep drawdowns.
- Income: Dividend is small or irregular.
Returns
| 1 week | −10.5% |
|---|---|
| 1 month | −14.9% |
| 3 months | −33.4% |
| 6 months | +38.2% |
| 1 year | +57.2% |
| 3 years | +85.5% |
| 5 years | +24.4% |
Signals
| 50-day / 200-day average | 979.26 / 772.10 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 69.93 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 16 Jul 2026 | TWD 5.7000 |
| 31 Dec 2025 | TWD 2.0000 |
| 16 Jul 2025 | TWD 6.0000 |
| 10 Jan 2025 | TWD 5.0000 |
| 18 Jul 2024 | TWD 11.0000 |
| 19 Jan 2024 | TWD 8.0000 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Taiwan OTC Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.